Cite
Katisko K, Cajanus A, Huber N, et al. GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance. J Neurol Neurosurg Psychiatry. 2021;92(12):1305-1312doi: 10.1136/jnnp-2021-326487.
Katisko, K., Cajanus, A., Huber, N., Jääskeläinen, O., Kokkola, T., Kärkkäinen, V., Rostalski, H., Hartikainen, P., Koivisto, A. M., Hannonen, S., Lehtola, J. M., Korhonen, V. E., Helisalmi, S., Koivumaa-Honkanen, H., Herukka, S. K., Remes, A. M., Solje, E., & Haapasalo, A. (2021). GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance. Journal of neurology, neurosurgery, and psychiatry, 92(12), 1305-1312. https://doi.org/10.1136/jnnp-2021-326487
Katisko, Kasper, et al. "GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance." Journal of neurology, neurosurgery, and psychiatry vol. 92,12 (2021): 1305-1312. doi: https://doi.org/10.1136/jnnp-2021-326487
Katisko K, Cajanus A, Huber N, Jääskeläinen O, Kokkola T, Kärkkäinen V, Rostalski H, Hartikainen P, Koivisto AM, Hannonen S, Lehtola JM, Korhonen VE, Helisalmi S, Koivumaa-Honkanen H, Herukka SK, Remes AM, Solje E, Haapasalo A. GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance. J Neurol Neurosurg Psychiatry. 2021 Dec;92(12):1305-1312. doi: 10.1136/jnnp-2021-326487. Epub 2021 Jun 29. PMID: 34187866.
Copy
Download .nbib